Rabbit Recombinant Monoclonal SIRT3 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 43 publications.
View Alternative Names
SIR2L3, SIRT3, hSIRT3, NAD-dependent protein delactylase sirtuin-3, Regulatory protein SIR2 homolog 3, SIR2-like protein 3
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIRT3 antibody [EPR19755] (AB217319)
Immunohistochemical analysis of paraffin-embedded human liver tissue labeling SIRT3 with ab217319 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) ready to use. Cytoplasmic staining on human liver is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIRT3 antibody [EPR19755] (AB217319)
Immunohistochemical analysis of paraffin-embedded human colon tissue labeling SIRT3 with ab217319 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) ready to use. Cytoplasmic staining on human colon is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIRT3 antibody [EPR19755] (AB217319)
Immunohistochemical analysis of paraffin-embedded human hepatocellular carcinoma tissue labeling SIRT3 with ab217319 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) ready to use. Cytoplasmic staining on human hepatocellular carcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
According to the literature [PMID : 24774224] : IHC and WB studies both showed a decreased expression of SIRT3 in tumor tissues compared with peritumor tissues. Our IHC-P results also showed decreased expression on about 58% of hepatocellular carcinoma.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIRT3 antibody [EPR19755] (AB217319)
Immunohistochemical analysis of paraffin-embedded human colon adenocarcinoma tissue labeling SIRT3 with ab217319 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on human poor- differentiated colon adenocarcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
According to the literature [PMID : 25105144] : SIRT3 expression level was found to be significantly associated with the lymph node metastasis and tumor stages. Our IHC-P results show that about 25% of poor-differentiated colon carcinoma show decreased expression.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SIRT3 antibody [EPR19755] (AB217319)
Immunohistochemical analysis of paraffin-embedded human colon adenocarcinoma tissue labeling SIRT3 with ab217319 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) ready to use. Cytoplasmic staining on human well-differentiated colon adenocarcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Our IHC-P results show that about 75% of well-differentiated colon carcinoma show increased expression.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-SIRT3 antibody [EPR19755] (AB217319)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1-3 : 3 minutes; Lane 4 : 15 seconds.
All lanes:
Western blot - Anti-SIRT3 antibody [EPR19755] (ab217319) at 1/1000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Lane 4:
Human fetal liver lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 43 kDa
Observed band size: 28 kDa
false
- WB
Supplier Data
Western blot - Anti-SIRT3 antibody [EPR19755] (AB217319)
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 12186850).
All lanes:
Western blot - Anti-SIRT3 antibody [EPR19755] (ab217319) at 1/1000 dilution
Lane 1:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
HT-29 (Human colorectal adenocarcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 43 kDa
Observed band size: 28 kDa
false
Exposure time: 30s
Related conjugates and formulations (8)
-
Anti-SIRT3 antibody [EPR19755] - BSA and Azide free
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-SIRT3 antibody [EPR19755]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-SIRT3 antibody [EPR19755]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SIRT3 antibody [EPR19755]
-
660 APC
APC Anti-SIRT3 antibody [EPR19755]
-
578 PE
PE Anti-SIRT3 antibody [EPR19755]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-SIRT3 antibody [EPR19755]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-SIRT3 antibody [EPR19755]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SIRT3 modulates energy homeostasis by deacetylating and regulating enzymes involved in metabolism. It is a part of the mitochondrial sirtuin family contributing to fatty acid oxidation and the antioxidant defense system. By targeting key metabolic enzymes SIRT3 directly impacts the tricarboxylic acid (TCA) cycle and oxidative phosphorylation processes. These functions highlight its role in maintaining energy efficiency and reducing reactive oxidative species.
Pathways
SIRT3 participates in vital metabolic pathways such as the TCA cycle and the urea cycle. It interacts with other proteins like MnSOD and IDH2 to enhance mitochondrial function and overall cellular metabolism. This helps control the balance between energy production and consumption integrating signals from the AMPK and NAD+-dependent pathways to coordinate responses to changes in energy availability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (43)
Recent publications for all applications. Explore the full list and refine your search
Materials today. Bio 34:102234 PubMed40893347
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1608156 PubMed40777993
2025
Applications
Unspecified application
Species
Unspecified reactive species
Archives of rheumatology 40:197-210 PubMed40757971
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental medicine 25:267 PubMed40736712
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 17:4187-4197 PubMed40672597
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1524219 PubMed40635757
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 20:542 PubMed40442713
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:3011-3029 PubMed40384870
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brain sciences 15: PubMed40309794
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and applied biochemistry 72:805-824 PubMed39690748
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com